A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USING HIGH THROUGHPUT M...
A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USING HIGH THROUGHPUT MOLECULAR DYNAMICS
Since 10 years, Acellera is at the forefront in the development of Molecular Dynamics (MD) applications for drug discovery, and is committed to developing next generation tools that facilitate adoption of this technology by a wide...
ver más
ACELLERA LABS
Investigacion,diseño,desarrollo,produccion,montaje y comercializacion de productos electronicos e informaticos de toda indole,tanto de softw...
TRL
4-5
| 89K€
Fecha límite participación
Sin fecha límite de participación.
Financiación
concedida
El organismo H2020 notifico la concesión del proyecto
el día 2018-08-31
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
HTMD
Feasibility assessment of a cloud application platform for r...
71K€
Cerrado
BINARYBIO
Commercialization of distributed cloud solutions for biomo...
137K€
Cerrado
ScalaLife
Scalable Software Services for Life Science
4M€
Cerrado
ATLAS
Next generation HPC/QC in silico drug discovery platform for...
4M€
Cerrado
PTQ-17-09079
Aplicaciones web basadas en simulaciones y aprendizaje autom...
98K€
Cerrado
iEBDD
A Software Interface for Interactive Ensemble Based Drug Des...
150K€
Cerrado
Información proyecto Cloud-HTMD
Duración del proyecto: 18 meses
Fecha Inicio: 2017-02-27
Fecha Fin: 2018-08-31
Líder del proyecto
ACELLERA LABS
Investigacion,diseño,desarrollo,produccion,montaje y comercializacion de productos electronicos e informaticos de toda indole,tanto de softw...
TRL
4-5
| 89K€
Presupuesto del proyecto
75K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Since 10 years, Acellera is at the forefront in the development of Molecular Dynamics (MD) applications for drug discovery, and is committed to developing next generation tools that facilitate adoption of this technology by a wider segment of the drug discovery community.
Acellera’s strategy is to develop a powerful cloud-computing platform to widen access to high-throughput molecular dynamics simulations SaaS solution (Software as a Service). The aim is to accelerate market uptake of computational drug discovery and drive down the cost of development in the pharmaceutical industry. To this end a new software technology platform was released recently open source (HTMD.org) in order to help create a large community of scientists acquainted with our technology. HTMD aims to help dramatically accelerated pre-clinical research and to provide an order of magnitude increase in productivity compared to traditional in-vitro screenings.
In this project, Acellera proposes a new integrated computational chemistry solution for Cloud computing. The objectives that Acellera would like to achieve by recruiting an Innovation Associate are a) to develop a web-application to facilitate the use HTMD on cloud for biotech companies and smaller pharmaceutical companies, and b) to develop an innovative medicinal chemistry protocols via a web based and cloud-powered infrastructure.
The IA will be in charge of solving an industrial problem reported by the market. The development of the new tools will allow answering the unmet need to enable any small, medium company to perform similar in-silico protocols of top-pharmaceutical companies for accelerating their discovery pipelines.